Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North AmericaJennifer K Quint, Yvette M. Weesie, Brandie Walker et al.|The Journal of Allergy and Clinical Immunology In Practice|2022Cited by 79
Step-Up Therapy in Black Children and Adults with Poorly Controlled AsthmaMichael E. Wechsler, Christine A. Sorkness, Stanley J. Szefler et al.|New England Journal of Medicine|2019Cited by 67
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trialMario Castro, Juby A Jacob-Nara, Alberto Papi et al.|The Lancet Respiratory Medicine|2025Cited by 67
Response to Biologics Along a Gradient of T2 Involvement in Patients With Severe Asthma: A Data-Driven Biomarker Clustering ApproachEileen Wang, Bassam Mahboub, William Henley et al.|The Journal of Allergy and Clinical Immunology In Practice|2025Cited by 1